Time & Date: 3 September, 16:30 – 17:30 CEST
Chairpersons: C. Dinah UK & F. Ghanchi UK
Speakers & Presentations:
C. Dinah UK
16:30 Introduction
K. Balalaskas UK
16:32 Tele-ophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease: the HERMES study
17:40 Discussion
T. Jackson UK
16:44 Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER)
16:52 Discussion
R. MacLaren UK
16:56 Update on gene therapy trials for Geographic Atrophy
17:04 Discussion
C. Dinah UK
17:08 Strengthening AMD Trials: Patient and public involvement and inclusivity
17:16 Discussion
F. Ghanchi UK
17:20 Delivering industry-sponsored AMD trials in the UK: the NIHR model
17:28 Discussion
